FLT3 and acute myeloid leukemia: FLT3 internal tandem duplication (ITD) is the most common mutation, affecting 25% of de novo AML cases [2], and additional tyrosine kinase mutations (FLT3-TKD) in codons D385 and I386 have been observed in 5–10% of cases [3].